Status:
COMPLETED
Misoprostol for Preventing Postpartum Hemorrhage
Lead Sponsor:
Gynuity Health Projects
Collaborating Sponsors:
University of Witwatersrand, South Africa
Effective Care Research Unit
Conditions:
Postpartum Hemorrhage
Eligibility:
FEMALE
Phase:
NA
Brief Summary
This hospital-based, multicenter, randomized, placebo-controlled trial will assess the effects of misoprostol as part of active management of the third stage of labor on postpartum blood loss, complic...
Eligibility Criteria
Inclusion
- Women who have given birth to 1 or more live-born infants (para 1 or more)
- Vaginal delivery
Exclusion
- Refusal or inability to give informed consent
- Delivery regarded as abortion according to local gestational age limits
- Inability to take misoprostol sublingually
- Cesarean section
- Assisted vaginal delivery
Key Trial Info
Start Date :
August 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2007
Estimated Enrollment :
1200 Patients enrolled
Trial Details
Trial ID
NCT00124540
Start Date
August 1 2005
End Date
October 1 2007
Last Update
May 28 2008
Active Locations (5)
Enter a location and click search to find clinical trials sorted by distance.
1
University College Hospital
Ibadan, Nigeria
2
Tembisa Hospital
Johannesburg, South Africa
3
Rob Ferreira Hospital
Mbombela, South Africa
4
Dora Nginza Hospital
Port Elizabeth, South Africa